On a related note, a small biotech company has developed a better microarray technique to gauge even smaller copy number variants (CNVs) in autism. Up until now, the technology really was only capable of detecting large CNVs.
http://www.bio-itworld.com/2012/12/13/p ... -cnvs.html
For those who don't know what a CNV is, the genome is loaded with repetitious elements. Sometimes these are huge, involving more than a 1000 base pairs; sometimes they're as small as three nucleotides. CNV refers to repeat elements which occur consecutively, like CAGCAGCAGCAG. In the case of autism, there are increased occurrences of CNVs, either in the form of more duplications of a particular element, e.g., CAGCAGCAGCAGCAGCAGCAGCAG, or deletions of a typical repeat, e.g., CAGCAG.
These repeats are often sites for enhanced genome instability and that instability seems to lead to further changes in CNV. The CAG and CTG repeats of Fragile X are an excellent example. This site is a known "fragile site"-- meaning it's even more prone to breakages than most sites-- and the syndrome is defined by 200+ CAG/CTG repeats. Carriers of ~55-<200 repeats do have unstable genomes within the Fragile X site, but they don't seem to have any obvious manifestations other than the fact that they are more prone to having children with the full syndrome. Within the fullblown syndrome, when there are so many CAG/CTG repeats, these areas can be targeted by methylation, which often targets C and G rich areas (CAG/CTG) and are known as CpG islands. Anywho, the hypermethylation prevents transcription of the local gene, such that the product, FMRP, has reduced or deleted transcription (i.e., DNA > RNA product).
Cool stuff, huh? 